SpringerLink
Log in

Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Gonadotropin-releasing hormone agonists (GnRHa) have been widely used for decades to treat patients with central precocious puberty (CPP). Several studies have investigated changes in body composition in patients with CPP following GnRHa treatment, but the results are inconsistent. The aim of this study was to investigate changes in body mass index (BMI) in children treated with GnRHa for 2 years. We also assessed whether BMI affects treatment outcomes. This study included 383 girls (214 girls with central precocious puberty and 169 girls who underwent early puberty) treated with depot leuprolide acetate monthly for at least 2 years. We analyzed changes in BMI standard deviation score (SDS). Furthermore, blood luteinizing hormone (LH) levels were determined 30 min after depot leuprolide acetate administration every 6 months to evaluate adequate suppression of the hypothalamic-pituitary-gonadal axis. Pretreatment mean BMI SDS values were 0.07 ± 0.69, 1.29 ± 0.16, and 1.95 ± 0.32 in the normal weight, overweight, and obese subjects, respectively. Mean BMI SDS values after 2 years of treatment increased significantly only in normal weight children (0.07 ± 0.69 vs. 0.25 ± 0.73, P < 0.001). LH levels 30 min after leuprolide injection after 2 years of treatment were not different among normal weight, overweight, and obese subjects. Although the difference in BMI SDS was relatively small, it standard deviation score increased significantly after 2 years of treatment in normal weight girls with early pubertal development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. J.C. Carel, J. Leger, Clinical practice. Precocious puberty. N. Engl. J. Med. 358, 2366–2377 (2008)

    Article  CAS  PubMed  Google Scholar 

  2. J.C. Carel, E.A. Eugster, A. Rogol et al., Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123, e752–e762 (2009)

    Article  PubMed  Google Scholar 

  3. F. Antoniazzi, G. Zamboni, Central precocious puberty: current treatment options. Paediatr. Drugs 6, 211–231 (2004)

    Article  PubMed  Google Scholar 

  4. M.L. de Kroon, C.M. Renders, J.P. van Wouwe et al., The Terneuzen Birth Cohort: BMI change between 2 and 6 years is most predictive of adult cardiometabolic risk. PLoS One 5, e13966 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  5. D.J. Barker, C. Osmond, T.J. Forsen et al., Trajectories of growth among children who have coronary events as adults. N. Engl. J. Med. 353, 1802–1809 (2005)

    Article  CAS  PubMed  Google Scholar 

  6. A.M. Pasquino, I. Pucarelli, F. Accardo et al., Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. J. Clin. Endocrinol. Metab. 93, 190–195 (2008)

    Article  CAS  PubMed  Google Scholar 

  7. S. Heger, C.J. Partsch, W.G. Sippell, Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J. Clin. Endocrinol. Metab. 84, 4583–4590 (1999)

    CAS  PubMed  Google Scholar 

  8. W. Oostdijk, B. Rikken, S. Schreuder et al., Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch. Dis. Child. 75, 292–297 (1996)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. W.F. Paterson, E. McNeill, D. Young et al., Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Clin. Endocrinol. 61, 626–634 (2004)

    Article  CAS  Google Scholar 

  10. M.R. Palmert, M.J. Mansfield, W.F. Crowley Jr. et al., Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J. Clin. Endocrinol. Metab. 84, 4480–4488 (1999)

    CAS  PubMed  Google Scholar 

  11. T. Arrigo, F. De Luca, F. Antoniazzi et al., Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. Eur. J. Endocrinol. 150, 533–537 (2004)

    Article  CAS  PubMed  Google Scholar 

  12. B. Wolters, N. Lass, T. Reinehr, Treatment with gonadotropin-releasing hormone analogues: different impact on body weight in normal-weight and overweight children. Horm. Res. Paediatr. 78, 304–311 (2012)

    Article  CAS  PubMed  Google Scholar 

  13. M.D. Wheeler, Physical changes of puberty. Endocrinol. Metab. Clin. North Am. 20, 1–14 (1991)

    CAS  PubMed  Google Scholar 

  14. S. Heger, W.G. Sippell, C.J. Partsch, Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty years of experience. Endocr. Dev. 8, 94–125 (2005)

    PubMed  Google Scholar 

  15. S. Bhatia, E.K. Neely, D.M. Wilson, Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy. Pediatrics 109, E30 (2002)

    Article  PubMed  Google Scholar 

  16. W.W. Greulich, S.I. Pyle. Radiologic Atlas of Skeletal Development of the Hand and Wrist. 2nd edn., Stanford University Press, Standford (1959)

    Google Scholar 

  17. J.S. Moon, S.Y. Lee, C.M. Nam et al., 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J. Pediatr. 51, 1–25 (2008)

    Article  Google Scholar 

  18. N. Bayley, S.R. Pinneau, Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J. Pediatr. 40, 423–441 (1952)

    Article  CAS  PubMed  Google Scholar 

  19. C.B. Ebbeling, D.B. Pawlak, D.S. Ludwig, Childhood obesity: public-health crisis, common sense cure. Lancet 360, 473–482 (2002)

    Article  PubMed  Google Scholar 

  20. P.B. Kaplowitz, Link between body fat and the timing of puberty. Pediatrics 121(Suppl 3), S208–S217 (2008)

    Article  PubMed  Google Scholar 

  21. C.B. Jasik, R.H. Lustig, Adolescent obesity and puberty: the “perfect storm”. Ann. N Y Acad. Sci. 1135, 265–279 (2008)

    Article  CAS  PubMed  Google Scholar 

  22. D.B. Dunger, M.L. Ahmed, K.K. Ong, Early and late weight gain and the timing of puberty. Mol. Cell. Endocrinol. 254-255, 140–145 (2006)

    Article  CAS  PubMed  Google Scholar 

  23. M.A. Magiakou, D. Manousaki, M. Papadaki et al., The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J. Clin. Endocrinol. Metab. 95, 109–117 (2010)

    Article  CAS  PubMed  Google Scholar 

  24. K.O. Klein, K.M. Barnes, J.V. Jones et al., Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J. Clin. Endocrinol. Metab. 86, 4711–4716 (2001)

    Article  CAS  PubMed  Google Scholar 

  25. A.L. Aguiar, A.C. Couto-Silva, E.J. Vicente et al., Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues. J. Pediatr. Endocrinol. Metab. 19, 1327–1334 (2006)

    Article  CAS  PubMed  Google Scholar 

  26. J.P. Wilding, Neuropeptides and appetite control. Diabet. Med. 19, 619–627 (2002)

    Article  CAS  PubMed  Google Scholar 

  27. M.R. Palmert, S. Radovick, P.A. Boepple, The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty. J. Clin. Endocrinol. Metab. 83, 1091–1096 (1998)

    CAS  PubMed  Google Scholar 

  28. C. Maffeis, R. Franceschi, P. Moghetti et al., Circulating ghrelin levels in girls with central precocious puberty are reduced during treatment with LHRH analog. Eur. J. Endocrinol. 156, 99–103 (2007)

    Article  CAS  PubMed  Google Scholar 

  29. J.A. De Bond, J.T. Smith, Kisspeptin and energy balance in reproduction. Reproduction 147, R53–63 (2014)

    Article  PubMed  Google Scholar 

  30. I.M. van der Sluis, A.M. Boot, E.P. Krenning et al., Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J. Clin. Endocrinol. Metab. 87, 506–512 (2002)

    Article  PubMed  Google Scholar 

  31. J. Pich, M. Bibiloni Mdel, A. Pons et al., Weight self-regulation process in adolescence: the relationship between control weight attitudes, behaviors, and body weight status. Front. Nutr. 2, 14 (2015)

    Article  PubMed  PubMed Central  Google Scholar 

  32. E.M. Forman, M.L. Butryn, A new look at the science of weight control: how acceptance and commitment strategies can address the challenge of self-regulation. Appetite 84, 171–180 (2015)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Ajou University School of Medicine, Ajou University Hospital, San 5, Wonchondong, Yeongtong-gu, Suwon, Korea

    Hae Sang Lee, Jong Seo Yoon, Jung Ki Roh & ** Soon Hwang

Authors
  1. Hae Sang Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jong Seo Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jung Ki Roh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. ** Soon Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to ** Soon Hwang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, H.S., Yoon, J.S., Roh, J.K. et al. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty. Endocrine 54, 497–503 (2016). https://doi.org/10.1007/s12020-016-1023-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1023-5

Keywords

Search

Navigation